Adamis Pharmaceuticals Corporation (ADMP) Ownership

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0.75
Day's range
$0.79

Adamis Pharmaceuticals Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARMISTICE CAPITAL, LLC 05/15/2023 14.50 M $1.68 M   100.00% 9.48%
VANGUARD GROUP INC 07/14/2023 6.48 M $751.49 K   0.00% 4.24%
BLACKROCK INC. 05/12/2023 2.77 M $320.69 K   -0.03% 1.81%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2023 1.33 M $153.76 K   0.00% 0.87%
STATE STREET CORP 05/15/2023 475.37 K $55.10 K   0.00% 0.31%
CITADEL ADVISORS LLC 05/15/2023 327.17 K $37.92 K   100.00% 0.21%
TOWER RESEARCH CAPITAL LLC (TRC) 05/09/2023 268.78 K $31.00 K   4.01% 0.18%
NORTHERN TRUST CORP 05/15/2023 244.63 K $28.35 K   0.00% 0.16%
HRT FINANCIAL LP 05/12/2023 143.86 K $16.00 K   991.00% 0.09%
UBS GROUP AG 05/12/2023 128.20 K $14.87 K   213.01% 0.08%
MORGAN STANLEY 05/15/2023 114.22 K $13.24 K   11.41% 0.07%
EDMOND DE ROTHSCHILD HOLDING S.A. 05/11/2023 100.00 K $11.59 K   0.00% 0.07%
CAPITAL CS GROUP, LLC 04/07/2023 94.10 K $10.91 K   2.26% 0.06%
BANK OF NEW YORK MELLON CORP 05/09/2023 84.00 K $9.74 K   0.00% 0.05%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 05/11/2023 69.70 K $8.00 K   -0.43% 0.05%
VERDENCE CAPITAL ADVISORS LLC 04/24/2023 58.38 K $6.77 K   0.00% 0.04%
LIDO ADVISORS, LLC 05/15/2023 46.72 K $5.42 K   0.00% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/16/2023 39.60 K $4.75 K   -86.12% 0.03%
REGIONS FINANCIAL CORP 05/12/2023 34.50 K $4.00 K   0.00% 0.02%
AFFINITY CAPITAL ADVISORS, LLC 04/11/2023 30.32 K $3.51 K   17.59% 0.02%
BANK OF AMERICA CORP /DE/ 05/12/2023 25.74 K $2.96 K   -35.38% 0.02%
TWO SIGMA SECURITIES, LLC 05/15/2023 24.63 K $2.85 K   -11.95% 0.02%
GLOBAL STRATEGIC INVESTMENT SOLUTIONS, LLC 04/20/2023 23.00 K $2.67 K   0.00% 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/16/2023 22.08 K $2.56 K   58.17% 0.01%
STONEBRIDGE CAPITAL ADVISORS LLC 05/12/2023 22.00 K $2.55 K   0.00% 0.01%
B. RILEY WEALTH ADVISORS, INC. 05/17/2023 20.00 K $2.32 K   0.00% 0.01%
RVW WEALTH, LLC 04/11/2023 19.00 K $2.20 K   0.00% 0.01%
VICTORY CAPITAL MANAGEMENT INC 05/02/2023 16.64 K $1.93 K   -1.29% 0.01%
CITADEL ADVISORS LLC 05/15/2023 14.90 K $1.73 K   -58.95% 0.01%
HARBOUR INVESTMENTS, INC. 05/15/2023 12.86 K $1.49 K   0.00% 0.01%
OPPENHEIMER & CO INC 05/10/2023 12.00 K $1.39 K   0.00% 0.01%
WELLS FARGO & COMPANY/MN 05/12/2023 11.04 K $1.28 K   981.00% 0.01%
WOLFF WIESE MAGANA LLC 04/18/2023 10.74 K $1.25 K   0.00% 0.01%
MGO ONE SEVEN LLC 05/08/2023 10.62 K $1.23 K   0.00% 0.01%
JANNEY MONTGOMERY SCOTT LLC 04/28/2023 10.00 K $1.00 K   0.00% 0.01%
SIMPLEX TRADING, LLC 04/27/2023 8.93 K $1.00 K   100.00% 0.01%
ADVISOR GROUP HOLDINGS, INC. 05/12/2023 6.19 K $718   -2.15% 0.00%
GROUP ONE TRADING, L.P. 05/12/2023 5.61 K $650   100.00% 0.00%
TIMESCALE FINANCIAL, INC. 04/24/2023 5.10 K $591   0.00% 0.00%
FOUNDERS CAPITAL MANAGEMENT 04/12/2023 5.00 K $1.00 K   0.00% 0.00%
CITADEL ADVISORS LLC 05/15/2023 4.20 K $487   -33.33% 0.00%
ALLWORTH FINANCIAL LP 04/18/2023 3.53 K $410   100.00% 0.00%
NEWEDGE ADVISORS, LLC 05/12/2023 2.70 K $313   100.00% 0.00%
HOLLENCREST CAPITAL MANAGEMENT 05/16/2023 2.00 K $232   0.00% 0.00%
BELPOINTE ASSET MANAGEMENT LLC 05/15/2023 900 $104   0.00% 0.00%
SIGNATUREFD, LLC 04/28/2023 863 $100   0.00% 0.00%
JPMORGAN CHASE & CO 05/18/2023 392 $0   -2.49% 0.00%
CAPE INVESTMENT ADVISORY, INC. 10/12/2023 100 $12   100.00% 0.00%
ROYAL BANK OF CANADA 05/15/2023 92 $0   64.29% 0.00%
WINCH ADVISORY SERVICES, LLC 05/10/2023 73 $0   0.00% 0.00%

Adamis Pharmaceuticals Corporation institutional Ownership - FAQ's

During the previous two years, 11 institutional investors and hedge funds held shares of Adamis Pharmaceuticals Corporation. The most heavily invested institutionals were:

TimeScale Financial, Inc.: 0

LADENBURG THALMANN FINANCIAL SERVICES INC.: 8,171

Sterling Global Strategies LLC: 12,240

FNY Managed Accounts LLC: 800

SII INVESTMENTS INC/WI: 10,000

Virtu KCG Holdings LLC: 38,474

18.04% of Adamis Pharmaceuticals Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 267.93 K shares in the last 24 months. This purchase volume represents approximately $208.99 K in transactions.